Search results

Page results

• Loss of smell a ‘highly specific’ indicator of Covid-19, finds UCLH and UCL research

  Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.

• Age no criterion for decisions on heart attack treatment, new research finds

  Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.

• Congratulations to our three RCN Nursing Award winners

  It’s a clean sweep for our nominees at this year’s RCN Nursing Awards. Congratulations to winners Jo Hargroves, Robert Vicente and Susie Lagrata!

• Single-dose radiotherapy as effective for treating breast cancer, long-term study finds

  A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.

• SUMMIT Study catches up with pre-pandemic follow up appointments

  As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.

• Having proton beam therapy: information for teenagers aged 13-17

  Having proton beam therapy: information for teenagers aged 13-17 patient information.

• Managing cancer treatment side effects videos

  This series of wellbeing videos have been designed to help people manage the side effects of cancer treatment.

• £1.2 million for trial of new weight loss treatment

  Researchers at UCLH and Imperial College Healthcare NHS Trust are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.

• What is acute myeloid leukaemia (AML)?

  Acute Myeloid Leukaemia (AML) is a form of cancer that develops in your bone marrow and affects your blood cells.

• Treating acute myeloid leukaemia (AML)

  Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.